Alzheimer disease: Mouse models pave the way for therapeutic opportunities

Archives of Neurology

Volumn 57, Issue 2, 2000, Pages 176-181

  Emilien, Gérard ^a,d   Maloteaux, Jean Marie ^a   Beyreuther, Konrad ^b   Masters, Colin L ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1; CHROMOSOME 14Q; CHROMOSOME 19; CHROMOSOME 21Q; COGNITIVE DEFECT; ENZYME ACTIVITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; NEUROTOXICITY; NONHUMAN; PEDIGREE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; TRANSGENE;

EID: 0033982103     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.2.176     Document Type: Review

References (30)

1. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer disease in a community population higher than previously reported. JAMA. 1989;262:2251-2256.
2. Russo C, Angelini G, Dapino D, et al. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc Natl Acad Sci USA. 1998;95:15598-155602.
3. Li QX, Maynard C, Cappai R, et al. Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J Neurochem. 1999;72:2479-87.
4. Hardy J, Duff K, Gwinn-Hardy K, Perez-Tur J, Hutton M. Genetic dissection of Alzheimer's disease and related dementias. Nat Neurosci. 1998;1:355-358.
5. Younkim SG. The APP and PS1/2 mutations linked to early onset Alzheimer's disease increase the extracellular concentration of alpha/beta 1-42(43). Clin Neurol. 1994;37:1099.
6. Blacker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. Nat Genet. 1998;19:357-360
7. Lenden CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics JAMA. 1997;277:825-831.
8. Lichtenthaler SF, Wang R, Grimm H, Uljon SN, Masters CL, Beyreuther K. Mechanism of the cleavage specificity of Alzheimer's disease γ-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci U S A. 1999;96:3053-3058.
9. Pedersen WA, Kloczewiak MA, Blusztajn JK. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A. 1996;93:8068-8071.
10. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754-760.
11. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996;2:864-870.
12. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
13. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977-1981.
14. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702-705.
15. Huang X, Atwood CS, Moir RD, et al. Zinc-induced Alzheimer's A beta 1-40 aggregation is mediated by conformational factors. J Biol Chem. 1997;272:26464-70.
16. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol. 1999;57:301-323.
17. Yan SD, Fu J, Soto C, et al. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 1997;389:589-695.
18. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1995; 373:523-527.
19. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99-102.
20. Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA. 1997;94:13287-13292.
21. Oster-Granite ML, Mcphie DL, Greenan J, Neve RL. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor protein. J Neurosci. 1996;16:6732-6741.
22. LiQ-X, Maynard C, Cappai R, et al. Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in hippocampus of aged transgenic mice. J Neurochem. 1999;72:2479-2487.
23. Duff K, Eckman C, Zehr C, et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996;383:710-713
24. Borchelt DR, Ratovitski T, Van Lare J, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressiing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939-945.
25. Holcomb L, Gordon MN, McGowan E, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998;4:97-100.
26. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat Genet. 1997;17:263-264.
27. Zheng H, Jiang M-H, Trumbauer ME, et al. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995; 81:525-531.
28. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 1997;89:629-639.
29. De Strooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391:387-390.
30. Smith MA, Hirai K, Hsiao K, et al. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem. 1998;70:2212-2215.